⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Vascular Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-14 — Alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction, and cardiovascular ageing.: [expert-opinion] Review, no new primary data: frames alcohol as a dose- and drinking-pattern-dependent cardiovascular stressor linking inter-organ crosstalk, microvascular dysfunction, and cellular senescence to vascular aging, while challenging moderate-drinking cardioprotection without establishing causal mediation by these aging mechanisms in humans. [expert-opinion] (novelty: 3)
- 2026-11-12 — NNMT Safeguards Vascular Aging by Modulating an Endothelial LMNA-HSP Stress-Response Axis.: [animal-model] Mouse study reports age-related loss of endothelial NNMT and rescue of arterial stiffness and impaired vasodilation after NNMT restoration via an LMNA–HSF1–heat-shock-protein stress-response axis, supporting a causal endothelial-protection mechanism in mice without establishing human efficacy or lifespan extension. [animal-model] (novelty: 3)
- 2026-11-09 — Senescence‐Associated Loss of α‐Synuclein in Brain Microvascular Endothelium Compromises Tight Junctions and Disrupts Blood–Brain Barrier Integrity: [mechanism-plausible] Preclinical mechanistic study links senescence-associated endothelial α-synuclein loss to impaired tight junctions and blood–brain barrier disruption, extending cerebrovascular senescence biology to a specific protein-loss mechanism without establishing human vascular outcomes or therapeutic efficacy. [mechanism-plausible] (novelty: 3)
- 2026-11-09 — The lncRNA SEPT5-GP1BB-encoded peptide ARP, upregulated by 17β-estradiol, retards HO-induced senescence of human umbilical vein endothelial cells by promoting autophagy.: [mechanism-plausible] Cultured human umbilical vein endothelial cell study reports that 17β-estradiol upregulates the SEPT5-GP1BB-encoded peptide ARP to promote autophagy and attenuate stress-induced senescence, identifying a candidate endothelial-protection pathway without demonstrating improved vascular function in vivo or clinical benefit. [mechanism-plausible] (novelty: 3)
- 2026-10-27 — Stage-dependent associations of Cardiovascular-Kidney-Metabolic Syndrome with Cognitive Decline, Depression, and Neuroimaging Signatures in multi-regional older adults.: [human-observational] Multi-regional observational cohort analysis (N=28,242) associates advanced cardiovascular-kidney-metabolic syndrome stages with faster cognitive decline and neuroimaging signatures of cerebrovascular damage, with modifiable factors including social isolation and physical inactivity statistically accounting for approximately one-quarter of cognitive impairment risk, without establishing causal mediation or the benefit achievable by changing those factors. [human-observational] (novelty: 3)
- 2026-07-30 — Circulating Amino Acids Independently Predict Longitudinal Progression of Cardio-Ankle Vascular Index in Japanese Older Adults: The Kyotango Longevity Cohort Study.: [human-observational] Three-year prospective Kyotango Longevity Cohort study in Japanese older adults associates higher baseline circulating leucine, isoleucine, and glutamic acid with faster cardio-ankle vascular index (CAVI) progression after statistical adjustment, without establishing causal vascular mechanisms or showing that lowering these amino acids reduces arterial stiffness. [human-observational] (novelty: 3)
- 2026-11-04 — Differences in cerebral haemodynamics associated with long-term endurance training in older adults.: [human-observational] Human observational neuroimaging study associates long-term endurance training in older adults with shorter cerebral arterial transit time, opposite to typical age-related lengthening, despite no significant differences in global resting cerebral blood flow or cognitive performance; it does not establish training-induced reversal of cerebrovascular aging or cognitive benefit. [human-observational] (novelty: 3)
- 2026-10-13 — Regional oxygen extraction fraction is higher in older adults with type 2 diabetes and obesity: associations with cognition and metabolic markers.: [human-observational] Human pilot QSM MRI study reports elevated regional cerebral oxygen extraction fraction in older adults with co-occurring type 2 diabetes and obesity, associated with worse executive function and altered adipokine levels, without establishing impaired oxygen delivery, causal vascular mechanisms, or benefit from intervention. [human-observational] (novelty: 3)
- 2026-10-23 — Leptin Neutralization Attenuates Inflammaging in Endothelial and Immune Cell Models.: [mechanism-plausible] Endothelial cell-model experiments report reduced senescence and inflammatory readouts after leptin receptor blockade, adding a candidate endocrine input to vascular senescence without demonstrating improved arterial function or clinical vascular outcomes. [mechanism-plausible] (novelty: 3)
- 2026-10-26 — Cardiovascular resilience in centenarians.: [expert-opinion] Review, no new primary data: cardiovascular resilience in centenarians is framed as marked structural aging coexisting with avoidance of overt clinical events through delayed pathology and adaptive compensation, with preserved insulin sensitivity and slower epigenetic aging proposed as contributors rather than established causes and survivorship selection limiting generalization. [expert-opinion] (novelty: 3)
- 2026-10-01 — Cardiometabolic dysfunction and age at natural menopause: a prospective study.: Prospective cohort of over 2,200 South Asian women [human-observational]: baseline hypertension independently predicted natural menopause approximately one year earlier, linking a vascular risk phenotype to subsequent reproductive aging without directly measuring vascular-aging mechanisms or establishing causality. [human-observational] (novelty: 3)
- 2026-11-05 — Resistant hypertension and accelerated vascular aging: evidence for PTEN-AKT-associated cellular senescence.: Human observational study links resistant hypertension in older and obese individuals to accelerated vascular aging and endothelial senescence [human-observational], with accompanying in vitro evidence implicating PTEN downregulation and AKT-dependent senescence [mechanism-plausible], without establishing causal direction in patients or benefit from targeting this pathway. [human-observational] (novelty: 3)
- 2026-10-28 — Identification of an Endothelial Senotype Predicted by Ion Channel Expression in Aged Murine Perigonadal Adipose Tissue.: Aged-mouse perigonadal adipose single-nucleus RNA-sequencing study [animal-model] maps a Mif-high senescence-associated state to capillary endothelial clusters and identifies ion-channel transport expression profiles as candidate predictors, without demonstrating impaired vascular function, benefit from channel modulation, or translation to human endothelium. [animal-model] (novelty: 3)
- 2026-10-29 — GLP-1 Receptor Agonists Decrease the Rate of Rupture, Cardiac Events, and Death in Patients with Abdominal Aortic Aneurysms.: Propensity-score-matched human observational cohort of over 27,000 patients with abdominal aortic aneurysm associated GLP-1 receptor agonist use with 46% lower aneurysm rupture and 53% lower five-year all-cause mortality, without establishing causality, a vessel-wall mechanism, or reversal of vascular aging; residual confounding remains possible [human-observational]. [human-observational] (novelty: 3)
- 2026-10-10 — Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.: 2026 BMAT review proposes bone marrow adipose expansion as a candidate contributor to vascular pathology via marrow-sourced inflammatory hematopoiesis, extending the cardiometabolic-vascular aging substrate menu to the marrow niche — narrative synthesis, causal and therapeutic relevance to CV outcomes explicitly unresolved. [expert-opinion] (novelty: 3)
- 2026-10-02 — Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults: Confirmatory 3-month RCT of oral nicotinamide riboside vs placebo in middle-aged/older adults with SBP 120–139 mmHg will test SBP and arterial stiffness endpoints, following a pilot that reported ~8 mmHg SBP reduction and lower arterial stiffness with NR — translates NAD+ precursor supplementation into a vascular-aging human endpoint program alongside the MitoQ, acetate, and fisetin vascular-aging trial protocols already logged. [human-rct] (novelty: 3)
- 2026-09-29 — α‐Synuclein Promotes Atherosclerosis by Impairing Macrophage Autophagic Flux: Preclinical mechanistic study: α-synuclein promotes atherosclerosis by impairing macrophage autophagic flux, adding a cross-hallmark (proteostasis→plaque-macrophage) node to atherogenic vascular aging — no human data. [animal-model] (novelty: 3)
- 2026-09-29 — IGF‐1/SLC25A33 Maintains Blood‐Labyrinth Barrier Integrity by Suppressing TGF‐β/Smad2‐Mediated Pericyte Activation in Age‐Related Hearing Loss: 2026 Aging Cell preclinical study extends pericyte-barrier biology into the cochlear vasculature: IGF-1/SLC25A33 restrains TGF-β/Smad2-mediated pericyte activation to preserve blood-labyrinth barrier integrity in age-related hearing loss, paralleling BBB-pericyte axes already logged. [animal-model] (novelty: 3)
- 2026-07-11 — Chronic subdural hematoma as failed resolution at the aged dura-subdural interface: Immune-vascular mechanisms, biomarker interpretation, and therapeutic translation.: 2026 CSDH failed-resolution review nominates aged dural neovasculature (fragile, leaky neomembrane vessels) as the vascular-aging substrate central to chronic subdural hematoma persistence, extending vascular-aging biology into the dura-subdural interface — synthesis only, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-03 — IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.: Preclinical IL-21R mAb blockade reduced atherosclerotic plaque initiation and residual inflammation in both young and aged LDL-receptor-deficient mice via Treg expansion and dampened Tfh–B-cell activity, adding IL-21/IL-21R to the roster of candidate cytokine-receptor targets for age-related atherosclerosis — mouse-only efficacy, human scRNAseq supports target expression. [animal-model] (novelty: 3)
- 2026-04-30 — Long-term cerebrovascular effects of cyclophosphamide and vincristine: endothelial senescence, impaired DNA repair signaling, and blood-brain barrier dysfunction.: 2026 mouse study: cyclophosphamide (not vincristine) produced persistent cerebrovascular endothelial senescence plus selective small-tracer BBB leak resembling a vascular-aging phenotype, adding a drug-induced cerebrovascular aging substrate relevant to chemo survivors and distinguishing BBB-permeability outcomes by chemotherapy class. [animal-model] (novelty: 3)
- 2026-07-28 — First-harmonic attenuation of radial pulse waves as a sensitive marker for vascular aging.: 2026 cross-sectional radial-pulse harmonic analysis (n=919, ages 6–92): first-harmonic attenuation (imaginary component Y) of radial pulse waves decreased significantly with age, proposed as a sensitive non-invasive vascular-aging marker complementary to conventional PWV — observational only, no outcome linkage. [human-observational] (novelty: 3)
- 2026-08-20 — Hyaluronan deficiency disrupts endothelial glycocalyx integrity and contributes to age-related arterial dysfunction.: 2026 preclinical in vivo study: endothelial HAS2 loss reduces hyaluronan, disrupts glycocalyx integrity, and produces impaired flow-mediated dilation and increased aortic stiffness — nominates endothelial hyaluronan/HAS2 as a glycocalyx-centered axis of age-related arterial dysfunction distinct from elastin, VSMC-senescence, and endothelial-senescence framings already logged. [animal-model] (novelty: 3)
- 2026-08-24 — Explaining Variance in Pulse Wave Velocity in Youth: The Youth Vascular Consortium.: 2026 Youth Vascular Consortium multi-cohort analysis (n=6763, ages 5–40): age, systolic BP, and heart rate were the strongest predictors of carotid-femoral pulse wave velocity but together explained <40% of variance, with waist circumference the leading anthropometric contributor — quantifies how much arterial-stiffness variance in youth remains unexplained by traditional hemodynamic/anthropometric risk factors, pointing to unmeasured genetic/prenatal/environmental drivers. [human-observational] (novelty: 3)
- 2026-10-03 — Compromised Elastin Network Load Transfer in Aging Human Aorta.: 2026 ex vivo multiscale biomechanics + imaging on purified human thoracic aortic elastin: male donors showed age-related fiber fragmentation, increased waviness, reduced lamellar continuity, and lower tensile stiffness, while female elastin networks were relatively preserved — localizes a sex-dimorphic load-bearing failure to the elastin network itself rather than inferring it from whole-wall mechanics, human tissue observational only. [human-observational] (novelty: 3)
- 2026-10-01 — Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.: 2026 review reframes endothelial TLR4 as a context-dependent driver of vascular senescence and nominates endothelium-targeted delivery (VCAM-1/E-selectin nanoparticles, engineered plant exosomes) as the way to retry TLR4 inhibition after systemic pan-TLR4 blockade failures — conceptual synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-07-03 — Body composition’s effect on the bone-vascular axis of osteoporosis discovered in AI-based CT analysis of COPD patients.: 2026 AI-based CT body-composition analysis in COPD patients: intermuscular adipose tissue (IMAT) was independently associated with total thoracic vascular calcification beyond age and BMI, while the classic inverse bone-density–calcification relationship held across body-composition phenotypes — observational, disease-specific (COPD) cohort, no causal or longitudinal data. [human-observational] (novelty: 3)
- 2026-07-07 — AI-driven advances in vascular aging research: From mechanisms to precision medicine.: 2026 AI-in-vascular-aging review consolidates already-active applications — multi-omics biomarker discovery, CT plaque/calcium quantification, and retinal- and PPG-based vascular aging clocks — as a precision-medicine layer on top of vascular-aging biology; synthesis of preclinical and observational work, no new mechanistic measurements. [expert-opinion] (novelty: 3)
- 2026-07-25 — SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.: 2026 aged-mouse + Sirt3-KO mouse + senescent HUVEC study: SIRT3 loss drives age-associated vascular impairment via mitochondrial dysfunction and endothelial-to-mesenchymal transition, nominating SIRT3 as a mitochondrial-sirtuin lever on endothelial EndMT distinct from (but parallel to) the FABP3/NF-κB EndMT axis already logged. [animal-model] (novelty: 3)
- 2026-04-08 — Extracellular matrix-associated molecules of senescent cells induce a senescence phenotype in proliferative cells via TGF-β signaling pathway.: 2026 preclinical study: ECM deposited by senescent vascular cells (and fibroblasts) is sufficient to drive endothelial senescence via TGF-β in vitro and after implantation in young mice, nominating senescent-cell matrisome as a vessel-wall-intrinsic, matrix-mediated route of vascular senescence propagation distinct from circulating SASP factors. [animal-model] (novelty: 3)
- 2026-06-16 — Resveratrol suppresses GATA4/Sortilin pathway to attenuate vascular smooth muscle cell senescence-associated secretory phenotype and vascular aging-related atherosclerosis.: 2026 ApoE mouse + cell study: resveratrol suppressed GATA4/Sortilin signaling in vascular smooth muscle cells to attenuate VSMC senescence/SASP and atherosclerosis, adding a specific transcriptional-pathway mechanism to the resveratrol-vascular-aging story — preclinical only, no human data. [animal-model] (novelty: 3)
- 2026-08-01 — Senescent cardiac cells promote thrombus formation and impair fibrinolysis.: 2026 in vitro human cardiac fibroblast + endothelial cell study: doxorubicin-induced senescent cardiac cells drove increased thrombin generation and impaired fibrinolysis, with rapamycin attenuation — adds a cardiac-senescence-to-prothrombotic-endothelium arm to vascular-aging biology (chemotherapy-induced cardiotoxicity context), cell-culture only. [mechanism-plausible] (novelty: 3)
- 2026-08-02 — Brain aging clocks: From methodological advances to cellular mechanisms.: 2026 brain aging clocks review implicates cerebrovascular and neurovascular aging as a contributor to accelerated brain-age readouts captured by multi-modal brain clocks, tying vascular-aging biology to brain-age quantification for neurodegenerative risk; synthesis only, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-07-07 — Circulating elastin fragments drive systemic aging: Where do pro-aging elastin fragments come from? A mini-review.: 2026 mini-review positions the aorta and large elastic arteries as a dominant anatomical source of circulating pro-aging elastin fragments generated by age-related elastolysis, framing arterial wall ECM breakdown as an upstream distributor of systemic aging signals rather than a locally confined vascular lesion — synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: 2026 ‘circulating senosome’ review nominates blood as the therapeutic interface through which vascular-origin SASP factors, EVs, and endothelial-derived mediators interact with other hallmark outputs systemically — synthesis consistent with the panvascular ‘pioneer organ’ framing already logged, no new vascular measurements. [mechanism-plausible] (novelty: 3)
- 2026-07-28 — Is amyloid beta peptide a driver of inflammaging?: 2026 Aβ-inflammaging review implicates age-related failure of vascular and perivascular Aβ clearance routes as a contributor to brain inflammaging, linking cerebrovascular aging biology (BBB, perivascular drainage) to Aβ-associated neuroinflammatory tone — narrative synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-08-10 — Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.: 2026 CSDH geroscience minireview frames the dural neomembrane’s aberrant neovascularization and endothelial fragility as a vascular-aging substrate central to chronic subdural hematoma recurrence, tying CSDH biology to the altered-intercellular-communication/vascular-aging axis the review highlights as strongest — synthesis only, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-28 — Comparison between exercise and hot water immersion on skin microvascular responses in older adults with overweight and obesity.: 2026 small randomized crossover acute trial in overweight older adults: a single 30-min 40°C hot water immersion produced larger acute improvements in OCT-measured skin microvascular diameter, velocity, flow, and density than time-matched moderate-intensity cycling, nominating passive heat as a vascular stimulus when exercise tolerance is limited — acute single-session skin-microvascular endpoints only, no chronic or outcome data. [human-rct] (novelty: 3)
- 2026-07-13 — PFDA exposure promotes myocardial aging and fibrosis via hyperactivation of the MTORC1 signaling axis.: 2026 preclinical PFDA study links a PFAS pollutant to myocardial (cardiomyocyte) senescence and fibrosis via MTORC1 hyperactivation; the lesion is cardiac-muscle rather than vascular-wall, extending the environmental-exposure menu of cardiovascular aging drivers but not reporting endothelial or arterial endpoints. [animal-model] (novelty: 3)
- 2026-07-24 — Circulating factors induced by time-restricted eating drive metabolic reprogramming in endothelial cells.: Serum-transfer experiment on human cerebromicrovascular endothelial cells: TRE-donor serum reprogrammed endothelium toward a stress-adaptive, catabolic state (ISR/ATF4 up, mTORC1 down, GDF15 induction, OXPHOS remodeling), extending TRE’s proposed vascular benefits to a cerebrovascular endothelial transcriptional signature — cell-culture only, no vascular-function endpoint. [mechanism-plausible] (novelty: 3)
- 2026-06-04 — Targeting NFAT5 attenuates high sodium-induced vascular aging by re-sensitizing senescent smooth muscle cells to apoptosis.: 2026 preclinical study: dietary high sodium accelerates vascular aging via NFAT5-driven Bcl-XL expression in VSMCs, producing apoptosis-resistant senescent smooth muscle cells; NFAT5 inhibitor KRN5 reversed the phenotype in mice — nominates sodium intake as a modifiable upstream input to VSMC senescence and NFAT5 as a candidate vascular senolytic target, no human data. [animal-model] (novelty: 3)
- 2026-09-12 — Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy: 2026 tauopathy-model preclinical study: astrocyte uptake of soluble pathogenic tau produced impaired neurovascular coupling alongside astrocyte senescence and mitochondrial injury, adding a tau/astrocyte route to cerebrovascular aging distinct from endothelial-senescence-centric accounts. [animal-model] (novelty: 3)
- 2026-09-25 — Fisetin to Improve Vascular Function in Older Adults: 2026 pilot RCT protocol tests whether intermittent fisetin improves endothelial function and aortic stiffness in older adults via reduced senescence/SASP and mitochondrial oxidative stress — extends senolytic candidate testing into a vascular-aging endpoint population alongside MitoQ and acetate protocols, no efficacy readout yet. [human-rct] (novelty: 3)
- 2026-09-14 — The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients: 2026 early-phase RCT protocol (n=60, obese hypertensives) will read out vascular function under oral specialized pro-resolving mediator (SPM) supplementation, extending resolution-pharmacology from animal endothelial studies into a human residual-cardiovascular-risk population — protocol only, no efficacy results. [human-rct] (novelty: 3)
- 2026-09-23 — Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice: 2026 aged atherosclerotic mouse study: therapeutic rapamycin attenuated atherosclerotic plaque inflammation in aged mice, adding mTOR-directed immune reprogramming to the roster of preclinical anti-vascular-aging levers in established plaque biology (not just endothelial senescence). [animal-model] (novelty: 3)
- 2026-09-19 — 3D-Printed and Biofabricated Scaffolds for Osteoporotic Bone Defect Repair: Mechanical Adaptation, Redox Control, Senescence Modulation and Osteoimmunomodulation.: 2026 scaffold-design review foregrounds age-related loss of type-H (CD31^hi/EMCN^hi) vessels as a proximal vascular-aging lesion in osteoporotic bone, argued to reinforce senescence and oxidative stress and to require dedicated angiogenic scaffold cues — synthesis of preclinical evidence, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: 2026 longitudinal HF proteomic-organ-age study: kidney and lung age gaps accelerate before adverse cardiac events and predict outcomes independently of NT-proBNP and troponin T, extending organ-specific proteomic aging as an HF prognostic layer that captures non-cardiac vascular/end-organ decline missed by conventional cardiac biomarkers. [human-observational] (novelty: 4)
- 2026-09-15 — Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory.: 2026 secondary proteomic analysis of a 12-week activity RCT (n=34, healthy older adults): aerobic exercise selectively induces a 33-protein immune/vascular plasma signature associated with improved episodic memory, offering a small-n human link between an aerobic-specific vascular protein program and a cognitive readout. [human-rct] (novelty: 3)
- 2026-09-16 — Sex-specific biological aging clocks across organs and omics.: 2026 sex-specific organ-aging clocks study finds female–male divergence in organ-resolved proteomic networks across 15 organ systems including cardiovascular tissues, implying vascular-aging trajectories and their disease/mortality predictions are misestimated by sex-pooled clocks — descriptive/predictive human observational evidence, no vascular intervention data. [human-observational] (novelty: 4)
- 2026-09-14 — APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health.: 2026 HABS-HD epistasis analysis (African American, Mexican American, non-Hispanic White): APOE–RAAS gene–gene interactions show population-specific associations with cognitive impairment risk stratified by APOE ε4 status — links the RAAS arm of vascular-aging biology to AD-relevant cognitive endpoints via ancestry-dependent genetic interaction rather than main-effect variants. [human-observational] (novelty: 3)
- 2026-09-16 — Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging.: 2026 mouse study: endothelial-specific C/EBPβ activation drives AEP-mediated NAMPT cleavage, systemic NAD depletion, endothelial senescence, vascular deterioration, and shortened lifespan; genetic AEP ablation, NAMPT N136A knock-in, NMN, or AEP inhibitor CP#11A (superior to NMN) rescue vascular phenotypes — positions the endothelium as a systemic NAD-controlling organ driving whole-body aging. [animal-model] (novelty: 4)
- 2026-09-12 — The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.: cross-connection with pin1-cis-p-tau-axis: Review extends the Pin1–cis P-tau axis into vascular cognitive impairment, linking a tauopathy driver to vascular-aging pathology as a convergent substrate. (novelty: 3)
- 2026-09-20 — Panvascular aging: The pioneer organ hypothesis, research models and future directions.: 2026 panvascular-aging review advances a ‘pioneer organ’ hypothesis in which the integrated circulatory network — especially the aortic arch — ages first and propagates senescence to other organs via secretory factors, extracellular vesicles, and impaired translation; consolidates primate multi-omics, arterial scRNA-seq, and human vascular organoids and proposes diagnostic criteria plus model-selection guidance — conceptual synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-25 — Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.: 2026 aged-mouse AT2R knockout study: AT2R deficiency drives cardiac fibrosis and systolic/diastolic dysfunction alongside senescence and inflammasome activation, extending the RAS-and-cardiovascular-aging story beyond AT1R-blocker cardioprotection to a receptor whose loss actively accelerates aged-heart pathology. [animal-model] (novelty: 3)
- 2026-09-15 — Reprogramming the Aging Type H Vascular Niche via Myeloid Angiogenic Cell-Derived Extracellular Vesicles: Mechanisms, Engineering Strategies, and Translational Perspectives.: 2026 review of MAC-derived EVs positions loss of Type H vessel density and aging-driven endothelial-niche dysfunction as a bone-vascular arm of vascular aging, distinguishing myeloid angiogenic cells from ECFCs and cataloging engineering strategies (preconditioning, cargo loading, targeting, scaffolds) to restore angiogenic–osteogenic coupling — narrative synthesis of preclinical data, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-14 — Cardiovascular frailty - an emerging frailty phenotype.: 2026 narrative review proposes ‘cardiovascular frailty’ as a distinct phenotype in which vascular ageing (arterial stiffness, endothelial dysfunction, BP dynamics) is an explicit constituent of a frailty construct, tying vascular-aging biology to a proposed clinical assessment category rather than to end-organ CV events alone — framing contribution, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-15 — Lymphatic rarefaction drives cardiac inflammaging.: 2026 preclinical claim that age-related cardiac lymphatic rarefaction drives myocardial inflammaging extends the vascular-aging concept beyond blood vessels to the lymphatic compartment as a distinct cardiac aging substrate — title-level only, no vessel-density or perfusion metrics on the page. [animal-model] (novelty: 3)
- 2026-09-21 — Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.: 2026 cross-sectional imaging study (n=457): peripheral inflammatory markers (cytokine composite, CRP, GFAP) tracked with white-matter microstructural alterations on multi-shell NODDI, indirectly supporting a peripheral-inflammation → cerebrovascular/white-matter aging link but not measuring vessel or perfusion endpoints directly. [human-observational] (novelty: 3)
- 2026-09-23 — Multidimensional Aging Trajectories Preceding Cardiovascular Events.: 2026 nested case-control within ASPREE (adults 70+, adjudicated CVD): frailty was elevated and intrinsic capacity and physical HRQOL depressed up to ~10 years before CVD events versus matched controls, with accelerated divergence in the final 5 years — pushes vascular-aging’s clinical horizon backward as a decade-long multidimensional functional prodrome rather than a peri-event decline. [human-observational] (novelty: 3)
- 2026-09-16 — Cross-organ crosstalk in brain-aging-related sarcopenia: Caudate iron accumulation impairs muscle health via blood-brain barrier dysfunction.: 2026 cross-organ MR/TWAS/mediation analysis nominates pericyte CYBRD1-driven BBB dysfunction (with reduced plasma TYRO3) as a mediator linking caudate iron accumulation to sarcopenia — extends BBB/pericyte aging biology from a neurodegeneration substrate to a systemic muscle-health determinant, human genetic evidence only. [human-observational] (novelty: 3)
- 2026-06-01 — Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration.: 2026 adipose–brain review implicates visceral-adipose-driven insulin resistance, endothelial inflammation, and BBB dysfunction as a cerebrovascular arm of the adipose-to-brain aging pathway — narrative synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-13 — FABP3 regulates vascular remodeling and endothelial-mesenchymal transition through NF-κB activation in aged mice fed a high-fat diet.: 2026 aged-mouse HFD study: FABP3 overexpression in carotid tissue activated NF-κB signaling, driving endothelial-mesenchymal transition and pathological vascular remodeling, with in vitro knockdown/rescue supporting causality — nominates a FABP3–NF-κB–EndMT axis as a combined-aging + diet-obesity driver of carotid remodeling. [animal-model] (novelty: 3)
- 2026-09-14 — GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.: cross-connection with dna-methylation-aging: Semaglutide clock-deceleration RCT evidence connects epigenetic aging readouts to the pre-existing GLP-1 RA vascular-aging cardioprotection paradigm already logged under inflammaging. (novelty: 3)
- 2026-09-11 — Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology: News-reported preclinical work invokes age-related BBB leakiness as one of three converging substrates (with dendritic-cell antigen presentation and microglial inflammation) enabling T-cell brain entry and tau pathology, tying cerebrovascular aging to an adaptive-immunity route into neurodegeneration. [mechanism-plausible] (novelty: 3)
- 2026-07-13 — Nanoparticles as an efficient strategy to eliminate senescent brain endothelial cells.: 2026 preclinical rat study: Navitoclax-loaded SA-β-gal-responsive nanoparticles cleared senescent brain endothelial cells, reduced BBB permeability, and partially restored exploratory behavior in naturally aged rats — adds cerebrovascular endothelial senescence to the list of vascular-aging targets addressable by targeted senolytic delivery. [animal-model] (novelty: 3)
- 2026-09-09 — Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.: 2026 C3a–C3AR1 review implicates chronic complement anaphylatoxin signalling in endothelial dysfunction and neurovascular-unit decline, with the strongest chronological-ageing evidence for cerebrovascular endothelium and pericytes — narrative synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-09-09 — Apolipoprotein(a)-rich electronegative HDL accelerates vascular aging and atherosclerosis by inducing endothelial senescence.: 2026 human observational study with mechanistic follow-up: elevated Apo(a)-rich electronegative HDL (H5) independently associates with carotid intima-media thickness and plaque burden and accelerates vascular aging by inducing p53–p21-mediated endothelial senescence — reframes HDL from quantity (HDL-C) to a quality/subfraction story upstream of atherosclerosis. [human-observational] (novelty: 3)
- 2026-09-10 — EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.: Pilot single-arm trial: 4 weeks of low-dose rapamycin (1 mg/day) increased cerebral blood flow >15% across multiple regions in healthy midlife APOE4 carriers, with little CBF effect in non-carriers — small, uncontrolled, but the first human genotype-stratified cerebrovascular readout for rapamycin. [human-rct] (novelty: 3)
- 2026-09-11 — Replicative and Air Pollution-Induced Senescence: Telomere Dysfunction, Mitochondrial Stress, and Modulatory Effects of Astragaloside IV in Endothelial and Vascular Smooth Muscle Cells.: 2026 in vitro study on human endothelial and vascular smooth muscle cells: PM2.5 (fine particulate matter) accelerated a telomere-dysfunction/mitochondrial-stress/senescence program with cell-type-specific severity, and Astragaloside IV (Astragalus membranaceus saponin) partially protected endothelium but not VSMCs — nominates an environmental (air pollution) driver of vascular aging plus a candidate TCM-derived vasoprotective compound, cell-culture only. [mechanism-plausible] (novelty: 3)
- 2026-08-05 — Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans: Adequately powered RCT protocol (20 mg/day MitoQ vs placebo, 3 months, n=56/group, adults ≥60) will test endothelial function and aortic stiffness endpoints, building on mouse restoration data and a small human pilot — protocol only, no results. [human-rct] (novelty: 3)
- 2026-08-24 — Bridging structure and function: triple network remodeling driven by white matter hyperintensities in vascular cognitive impairment.: 2026 case-control multimodal MRI in vascular cognitive impairment: white matter hyperintensity burden tracks with structural and functional remodeling of the default-mode, salience, and frontoparietal networks, and DMN–right FPN functional connectivity fully mediates the WMH–memory-impairment link — extends vascular aging into a triple-network mediation model of cognitive decline, but observational and cross-sectional. [human-observational] (novelty: 3)
- 2026-07-20 — Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women: Planned RCT will read out vascular function alongside physical function and aging biomarkers under semaglutide/tirzepatide-induced weight loss in postmenopausal women with obesity — tests whether potent GLP-1/GIP agonism shifts vascular-aging endpoints beyond glycemic/weight effects; protocol only, no results. [human-rct] (novelty: 3)
- 2026-08-31 — Acetate and Age-associated Arterial Dysfunction: 2026 protocol: planned 12-week RCT of oral acetate in adults 50+ hypothesizes improvements in endothelial function and large-elastic artery stiffness via reduced oxidative stress and increased NO bioavailability — protocol only, no results. [human-rct] (novelty: 3)
- 2026-08-12 — The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults: Mito-Frail: early-phase RCT protocol proposing MitoQ can improve central and cerebral vascular function and reduce oxidative stress in frail older adults — protocol only, no results. [human-rct] (novelty: 3)
- 2026-08-28 — Oxygenaging: A Physiological Framework for Geroscience: Aging Cell ‘Oxygenaging’ framework nominates vascular oxygen delivery (endothelial function, tissue perfusion, hypoxic signaling) as a central axis of the proposed physiological aging framework, positioning vascular aging as an upstream determinant of systemic oxygen supply–demand mismatch — conceptual framing only. [expert-opinion] (novelty: 3)
- 2026-05-25 — Pathological Mechanism-Inspired Biomimetic Nano-Senotherapy for Reversing Experimental Atherosclerosis in ApoEMice.: 2026 ApoE mouse preclinical: biomimetic neutrophil-membrane ROS-responsive nano-senotherapy (KYC dimer + Navitoclax) reversed established atherosclerotic plaques, adding plaque senescent-cell clearance combined with upstream MPO/ROS suppression as a candidate lever on vascular aging — mouse-only, no human data. [animal-model] (novelty: 3)
- 2026-06-22 — Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.: 2026 nested case-control NMR metabolomics in a large Chinese population cohort: age-related circulating lipoprotein (triglyceride-enriched) and small-molecule signatures show subtype-specific associations with ischemic stroke vs. intracerebral hemorrhage and partially mediate the age–stroke relationship beyond classical cardiometabolic risk factors — extends vascular-aging biology into a stroke-subtype-resolved human metabolomic mediation model. [human-observational] (novelty: 3)
- 2026-06-27 — Co-exposure to environmental lead and hypertension exacerbates anxiety and depression via mtDNA-mediated cGAS phase separation.: 2026 mouse study frames hypertension as a permissive vascular-aging state that synergizes with environmental lead exposure to drive CNS astrocyte senescence via mtDNA–cGAS signaling — links vascular aging to neuropsychiatric aging endpoints through a shared DNA-sensing axis. [animal-model] (novelty: 3)
- 2026-07-11 — From local to systemic: Spinal aging in the multi-organ aging network.: 2026 spinal-aging review implicates vertebral endplate microvascular aging and impaired disc nutrient/waste exchange as a vascular-aging contribution to degenerative spinal disease within the multi-organ aging network — conceptual synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-08-03 — Aging at the neurovascular interface: An integrative framework linking cardiovascular and cerebrovascular diseases.: 2026 NVI review positions vascular aging as one of four mechanistic axes (alongside neural, inflammatory, ECM) at a shared heart–brain neurovascular interface, extending vascular-aging biology into an explicit cardio-cerebrovascular comorbidity framework — conceptual synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
- 2026-08-07 — Cellular senescence in posterior segment neovascular diseases: A proposed feed-forward amplification model.: cross-connection with cellular-senescence: Frames retinal microvascular senescence and SASP as a feed-forward driver of pathological neovascularization in nAMD and PDR, linking ocular-tissue senescence biology to vascular aging mechanisms. (novelty: 3)
- 2026-08-05 — The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease.: cross-connection with inflammaging: Metainflammation review makes adipose-derived inflammaging the explicit mechanistic bridge to cardiovascular/vascular aging, tying the inflammaging page to the vascular-aging endpoint via a permissive-milieu model. (novelty: 3)
- 2026-08-01 — Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.: 2026 cardiometabolic-aging review situates vascular aging within a multi-organ crosstalk network in which adipose-, muscle-, gut-, and kidney-derived signals converge on endothelial and cardiomyocyte oxidative stress, autophagy failure, and senescence; RAAS/SGLT2 inhibitors, senolytics, myokine mimetics, and microbiota modulation are proposed as nodal levers — narrative synthesis, no new vascular measurements. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction, and cardiovascular ageing.
14-nov-2026
novelty 3
per-area 3
strengthens
Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)
13-nov-2026
novelty 2
per-area 2
strengthens
Vascular Senescence and Atherosclerotic Plaque Vulnerability
12-nov-2026
novelty 2
per-area 2
strengthens
NNMT Safeguards Vascular Aging by Modulating an Endothelial LMNA-HSP Stress-Response Axis.
12-nov-2026
novelty 3
per-area 3
strengthens
Calibrating Effects of a Novel Supplement Strategy on Vascular Measures of Aging
11-nov-2026
novelty 2
per-area 2
mentions
Postprandial Hypotension, Frailty and Post-Induction Hypotension in Older Patients Undergoing Noncardiac Surgery
10-nov-2026
novelty 2
per-area 2
mentions
Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy.
10-nov-2026
novelty 2
per-area 2
strengthens
Senescence‐Associated Loss of α‐Synuclein in Brain Microvascular Endothelium Compromises Tight Junctions and Disrupts Blood–Brain Barrier Integrity
09-nov-2026
novelty 3
per-area 3
strengthens
The lncRNA SEPT5-GP1BB-encoded peptide ARP, upregulated by 17β-estradiol, retards HO-induced senescence of human umbilical vein endothelial cells by promoting autophagy.
09-nov-2026
novelty 3
per-area 3
strengthens
Resistant hypertension and accelerated vascular aging: evidence for PTEN-AKT-associated cellular senescence.
05-nov-2026
novelty 3
per-area 3
strengthens
Differences in cerebral haemodynamics associated with long-term endurance training in older adults.
04-nov-2026
novelty 3
per-area 3
strengthens
Cerebral Small Vessel Disease and Its Associations with Cognitive Impairment, Gait Disturbance, and Europsychiatric Symptoms: A Narrative Review.
03-nov-2026
novelty 2
per-area 2
strengthens
Age: a modifiable risk factor for cardiovascular disease?
02-nov-2026
novelty 2
per-area 2
strengthens
GLP-1 Receptor Agonists Decrease the Rate of Rupture, Cardiac Events, and Death in Patients with Abdominal Aortic Aneurysms.
29-oct-2026
novelty 3
per-area 3
strengthens
Acute and Chronic Cardiovascular and Neuromuscular Effects of Blood Flow Restriction Resistance Training in Older Adults: A Systematic Review and Meta-Analysis.
28-oct-2026
novelty 3
per-area 2
strengthens
Identification of an Endothelial Senotype Predicted by Ion Channel Expression in Aged Murine Perigonadal Adipose Tissue.
28-oct-2026
novelty 3
per-area 3
strengthens
Stage-dependent associations of Cardiovascular-Kidney-Metabolic Syndrome with Cognitive Decline, Depression, and Neuroimaging Signatures in multi-regional older adults.
27-oct-2026
novelty 3
per-area 3
strengthens
Cardiovascular resilience in centenarians.
26-oct-2026
novelty 3
per-area 3
strengthens
Leptin Neutralization Attenuates Inflammaging in Endothelial and Immune Cell Models.
23-oct-2026
novelty 3
per-area 3
strengthens
Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications.
22-oct-2026
novelty 2
per-area 2
mentions
Cardiovascular health and longevity: where are we?
22-oct-2026
novelty 2
per-area 2
strengthens
Reduction of Arterial Stiffness Assessed by Cardio-Ankle Vascular Index Through Intra-Dialytic Aerobic Training.
15-oct-2026
novelty 2
per-area 2
strengthens
Associations Between Early Vascular Aging and Quality of Life in the Adult Population: Pooled Data From 2 Epidemiological Studies.
13-oct-2026
novelty 2
per-area 2
strengthens
Regional oxygen extraction fraction is higher in older adults with type 2 diabetes and obesity: associations with cognition and metabolic markers.
13-oct-2026
novelty 3
per-area 3
strengthens
Adropin signaling pathways in metabolic and non-metabolic disorders.
10-oct-2026
novelty 2
per-area 2
strengthens
Bone marrow adipose tissue in cardiometabolic disease: marrow niche remodeling, inflammatory hematopoiesis, and vascular pathology.
10-oct-2026
novelty 3
per-area 3
strengthens
Brain care score and retinal health: structural and metabolic insights from the UK Biobank.
09-oct-2026
novelty 3
per-area 2
mentions
Is there a role for senotherapeutics in the treatment of giant cell arteritis?
07-oct-2026
novelty 2
per-area 2
strengthens
AKG and Brain Health in Aging
06-oct-2026
novelty 2
per-area 2
mentions
Anti-CXCR3 Therapy Reduces Harmful Immune Cell Infiltration into the Brain
06-oct-2026
novelty 2
per-area 2
mentions
Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics
06-oct-2026
novelty 2
per-area 3
strengthens
Vascular Aging-Driven Tumor-Like Transformation of Vascular Smooth Muscle Cells in Atherosclerotic Cardiovascular Disease: Mechanisms and Therapeutic Targets.
06-oct-2026
novelty 2
per-area 3
strengthens
Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework.
06-oct-2026
novelty 3
per-area 2
mentions
A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.
06-oct-2026
novelty 3
per-area 2
mentions
Investigation of Brain Mechanisms Involved in the Urinary Continence Mechanism Associated With Aging
05-oct-2026
novelty 2
per-area 1
mentions
Beyond Inflammation: The NLRP3 Inflammasome as a Cellular and Mechanical Hub of Vascular Remodeling in Hypertension.
05-oct-2026
novelty 2
per-area 3
strengthens
Compromised Elastin Network Load Transfer in Aging Human Aorta.
03-oct-2026
novelty 3
per-area 3
strengthens
Cyclooxygenase-1-sensitive oxidative responses to thromboxane-prostanoid receptor activation during vascular aging and experimental menopause.
03-oct-2026
novelty 2
per-area 2
strengthens
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
02-oct-2026
novelty 3
per-area 3
strengthens
Cardiometabolic dysfunction and age at natural menopause: a prospective study.
01-oct-2026
novelty 3
per-area 3
strengthens
Young Mice Exhibit Increased Relative Ventricular Remodeling After AMI—A Longitudinal CMR Study
01-oct-2026
novelty 2
per-area 2
strengthens
Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.
01-oct-2026
novelty 3
per-area 3
strengthens
Retinal Vessel Traits and the Development of Balance Impairment: The Canadian Longitudinal Study on Aging.
01-oct-2026
novelty 3
per-area 2
strengthens
AI-Driven Multimodal Risk Assessment Combining CT Imaging Biomarkers and Frailty Scores for Enhanced Mortality Prediction in Surgery Patients.
01-oct-2026
novelty 3
per-area 1
mentions
Association between peripheral platelet markers and motoric cognitive risk syndrome: a cross-sectional analysis of data from the WCHAT study.
01-oct-2026
novelty 2
per-area 1
mentions
Joint trajectories of abdominal obesity and systolic blood pressure are associated with incident stroke in two prospective cohorts.
01-oct-2026
novelty 3
per-area 2
strengthens
Renovascular Disease and Its Impact on Endogenous Kidney Repair: Stem/Progenitor Cells.
30-sep-2026
novelty 2
per-area 2
strengthens
Effects of Concurrent Training plus Cricket Protein Hydrolysate Supplementation on Blood Pressure, Arterial Stiffness, and Heart Rate Variability in Older Adults: A Randomized Controlled Trial.
30-sep-2026
novelty 2
per-area 2
mentions
Cognitive impairment and cerebral hemodynamics in individuals with symptomatic peripheral artery disease.
29-sep-2026
novelty 2
per-area 2
mentions
α‐Synuclein Promotes Atherosclerosis by Impairing Macrophage Autophagic Flux
29-sep-2026
novelty 3
per-area 3
strengthens